Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2018, Article ID 8285653, 7 pages
https://doi.org/10.1155/2018/8285653
Research Article

Genetic Variant rs755622 Regulates Expression of the Multiple Sclerosis Severity Modifier D-Dopachrome Tautomerase in a Sex-Specific Way

1Innovative Drug Research and Bioinformatics Group, School of Pharmaceutical Sciences, Chongqing University, Chongqing, 401331, China
2Institute of Fungus Resources, College of Life Sciences, Guizhou University, Guiyang, 550025, China
3College of Pharmacy, Guiyang University of Chinese Medicine, Guian New Area, 550025, China

Correspondence should be addressed to Xiao Zou; nc.ude.uzg@uozx

Received 3 May 2018; Accepted 8 July 2018; Published 24 July 2018

Academic Editor: Marija Mostarica-Stojković

Copyright © 2018 Zhijie Han et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Sospedra and R. Martin, “Immunology of multiple sclerosis,” Annual Review of Immunology, vol. 23, pp. 683–747, 2005. View at Publisher · View at Google Scholar · View at Scopus
  2. E. M. Frohman, M. K. Racke, and C. S. Raine, “Multiple sclerosis--the plaque and its pathogenesis,” The New England Journal of Medicine, vol. 354, no. 9, pp. 942–955, 2006. View at Publisher · View at Google Scholar · View at Scopus
  3. S.-M. Orton, B. M. Herrera, I. M. Yee et al., “Sex ratio of multiple sclerosis in Canada: a longitudinal study,” The Lancet Neurology, vol. 5, no. 11, pp. 932–936, 2006. View at Publisher · View at Google Scholar · View at Scopus
  4. P. Browne, D. Chandraratna, C. Angood et al., “Atlas of multiple sclerosis 2013: a growing global problem with widespread inequity,” Neurology, vol. 83, no. 11, pp. 1022–1024, 2014. View at Publisher · View at Google Scholar
  5. S. Sawcer, R. J. M. Franklin, and M. Ban, “Multiple sclerosis genetics,” The Lancet Neurology, vol. 13, no. 7, pp. 700–709, 2014. View at Publisher · View at Google Scholar · View at Scopus
  6. N. A. Patsopoulos, “Genetics of Multiple Sclerosis: An Overview and New Directions,” Cold Spring Harbor Perspectives in Medicine, vol. 8, no. 7, 2018. View at Publisher · View at Google Scholar
  7. J. Bauer, I. Huitinga, W. Zhao, H. Lassmann, W. F. Hickey, and C. D. Dijkstra, “The role of macrophages, perivascular cells, and microglial cells in the pathogenesis of experimental autoimmune encephalomyelitis,” Glia, vol. 15, no. 4, pp. 437–446, 1995. View at Publisher · View at Google Scholar · View at Scopus
  8. T. Calandra and T. Roger, “Macrophage migration inhibitory factor: a regulator of innate immunity,” Nature Reviews Immunology, vol. 3, no. 10, pp. 791–800, 2003. View at Publisher · View at Google Scholar · View at Scopus
  9. G. M. Cox, A. P. Kithcart, D. Pitt et al., “Macrophage migration inhibitory factor potentiates autoimmune-mediated neuroinflammation,” The Journal of Immunology, vol. 191, no. 3, pp. 1043–1054, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. M. Niino, A. Ogata, S. Kikuchi, K. Tashiro, and J. Nishihira, “Macrophage migration inhibitory factor in the cerebrospinal fluid of patients with conventional and optic-spinal forms of multiple sclerosis and neuro-Behcet's disease,” Journal of the Neurological Sciences, vol. 179, no. 1-2, pp. 127–131, 2000. View at Publisher · View at Google Scholar · View at Scopus
  11. J. Bernhagen, R. Krohn, H. Lue et al., “MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment,” Nature Medicine, vol. 13, no. 5, pp. 587–596, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. N. Esumi, M. Budarf, L. Ciccarelli, B. Sellinger, C. A. Kozak, and G. Wistow, “Conserved gene structure and genomic linkage for D-dopachrome tautomerase (DDT) and MIF,” Mammalian Genome, vol. 9, no. 9, pp. 753–757, 1998. View at Publisher · View at Google Scholar · View at Scopus
  13. M. Merk, S. Zierow, L. Leng et al., “The D-dopachrome tautomerase (DDT) gene product is a cytokine and functional homolog of macrophage migration inhibitory factor (MIF),” Proceedings of the National Acadamy of Sciences of the United States of America, vol. 108, no. 34, pp. E577–E585, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. M. Merk, R. A. Mitchell, S. Endres, and R. Bucala, “D-dopachrome tautomerase (D-DT or MIF-2): Doubling the MIF cytokine family,” Cytokine, vol. 59, no. 1, pp. 10–17, 2012. View at Publisher · View at Google Scholar · View at Scopus
  15. G. Benedek, R. Meza-Romero, K. Jordan et al., “MIF and D-DT are potential disease severity modifiers in male MS subjects,” Proceedings of the National Acadamy of Sciences of the United States of America, vol. 114, no. 40, pp. E8421–E8429, 2017. View at Publisher · View at Google Scholar
  16. K. Ji, X. Wang, J. Li et al., “Macrophage Migration Inhibitory Factor Polymorphism Is Associated with Susceptibility to Inflammatory Coronary Heart Disease,” BioMed Research International, Article ID 315174, 2015. View at Publisher · View at Google Scholar
  17. A. Akcali, S. Pehlivan, M. Pehlivan, T. Sever, and M. Neyal, “Association of macrophage migration inhibitory factor gene promoter polymorphisms with multiple sclerosis in Turkish patients,” Journal of International Medical Research, vol. 38, no. 1, pp. 69–77, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. J. A. Baugh, S. Chitnis, S. C. Donnelly et al., “A functional promoter polymorphism in the macrophage migration inhibitory factor (MIF) gene associated with disease severity in rheumatoid arthritis,” Genes & Immunity, vol. 3, no. 3, pp. 170–176, 2002. View at Publisher · View at Google Scholar · View at Scopus
  19. B. J. Plant, C. G. Gallagher, R. Bucala et al., “Cystic fibrosis, disease severity, and a macrophage migration inhibitory factor polymorphism,” American Journal of Respiratory and Critical Care Medicine, vol. 172, no. 11, pp. 1412–1415, 2005. View at Publisher · View at Google Scholar · View at Scopus
  20. S. Yende, D. C. Angus, L. Kong et al., “The influence of macrophage migration inhibitory factor gene polymorphisms on outcome from community-acquired pneumonia,” The FASEB Journal, vol. 23, no. 8, pp. 2403–2411, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. X. Bao, G. Liu, Y. Jiang et al., “Cell adhesion molecule pathway genes are regulated by cis-regulatory SNPs and show significantly altered expression in Alzheimer's disease brains,” Neurobiology of Aging, vol. 36, no. 10, pp. 2904.e1–2904.e7, 2015. View at Publisher · View at Google Scholar · View at Scopus
  22. G. Liu, X. Bao, and R. Wang, “Expression quantitative trait loci regulate HNF4A and PTBP1 expression in human brains,” Proceedings of the National Acadamy of Sciences of the United States of America, vol. 112, no. 30, p. E3975, 2015. View at Publisher · View at Google Scholar · View at Scopus
  23. G. Liu, Y. Hu, S. Jin, F. Zhang, Q. Jiang, and J. Hao, “Cis-eQTLs regulate reduced LST1 gene and NCR3 gene expression and contribute to increased autoimmune disease risk,” Proceedings of the National Acadamy of Sciences of the United States of America, vol. 113, no. 42, pp. E6321–E6322, 2016. View at Publisher · View at Google Scholar · View at Scopus
  24. G. Liu, Y. Hu, S. Jin, and Q. Jiang, “Genetic variant rs763361 regulates multiple sclerosis CD226 gene expression,” Proceedings of the National Acadamy of Sciences of the United States of America, vol. 114, no. 6, pp. E906–E907, 2017. View at Publisher · View at Google Scholar · View at Scopus
  25. G. Liu, Y. Liu, Q. Jiang et al., “Convergent Genetic and Expression Datasets Highlight TREM2 in Parkinson’s Disease Susceptibility,” Molecular Neurobiology, vol. 53, no. 7, pp. 4931–4938, 2016. View at Publisher · View at Google Scholar
  26. Y. Hu, L. Cheng, Y. Zhang et al., “Rs4878104 contributes to Alzheimer’s disease risk and regulates DAPK1 gene expression,” Neurological Sciences, vol. 38, no. 7, pp. 1255–1262, 2017. View at Publisher · View at Google Scholar
  27. G. Liu, Y. Zhang, L. Wang et al., “Alzheimer’s Disease rs11767557 Variant Regulates EPHA1 Gene Expression Specifically in Human Whole Blood,” Journal of Alzheimer's Disease, vol. 61, no. 3, pp. 1077–1088, 2018. View at Publisher · View at Google Scholar
  28. G. Liu, F. Zhang, Y. Jiang et al., “Integrating genome-wide association studies and gene expression data highlights dysregulated multiple sclerosis risk pathways,” Multiple Sclerosis Journal, vol. 23, no. 2, pp. 205–212, 2017. View at Publisher · View at Google Scholar
  29. Z. Xiang, M. Xu, M. Liao et al., “Integrating Genome-Wide Association Study and Brain Expression Data Highlights Cell Adhesion Molecules and Purine Metabolism in Alzheimer’s Disease,” Molecular Neurobiology, vol. 52, no. 1, pp. 514–521, 2015. View at Publisher · View at Google Scholar
  30. G. Liu, Y. Xu, Y. Jiang, L. Zhang, R. Feng, and Q. Jiang, “PICALM rs3851179 variant confers susceptibility to alzheimer's disease in chinese population,” Molecular Neurobiology, vol. 54, no. 5, pp. 3131–3136, 2017. View at Publisher · View at Google Scholar
  31. G. Liu, F. Zhang, Y. Hu et al., “Genetic Variants and Multiple Sclerosis Risk Gene SLC9A9 Expression in Distinct Human Brain Regions,” Molecular Neurobiology, vol. 54, no. 9, pp. 6820–6826, 2017. View at Publisher · View at Google Scholar · View at Scopus
  32. Y. Zhang, L. Wang, H. Jia et al., “Genetic variants regulate NR1H3 expression and contribute to multiple sclerosis risk,” Journal of the Neurological Sciences, vol. 390, pp. 162–165, 2018. View at Publisher · View at Google Scholar
  33. Y. Hu, S. Jin, L. Cheng, G. Liu, and Q. Jiang, “Autoimmune disease variants regulate GSDMB gene expression in human immune cells and whole blood,” Proceedings of the National Acadamy of Sciences of the United States of America, vol. 114, no. 38, pp. E7860–E7862, 2017. View at Publisher · View at Google Scholar · View at Scopus
  34. A. Ramasamy, D. Trabzuni, S. Guelfi et al., “Genetic variability in the regulation of gene expression in ten regions of the human brain,” Nature Neuroscience, vol. 17, no. 10, pp. 1418–1428, 2014. View at Publisher · View at Google Scholar · View at Scopus
  35. G. T. Consortium, “Human genomics. The Genotype-Tissue Expression (GTEx) pilot analysis: multitissue gene regulation in humans,” Science, vol. 348, no. 6235, pp. 648–660, 2015. View at Google Scholar
  36. L. R. Lloyd-Jones, A. Holloway, A. McRae et al., “The Genetic Architecture of Gene Expression in Peripheral Blood,” American Journal of Human Genetics, vol. 100, no. 2, pp. 228–237, 2017. View at Publisher · View at Google Scholar
  37. D. V. Zhernakova, P. Deelen, M. Vermaat et al., “Identification of context-dependent expression quantitative trait loci in whole blood,” Nature Genetics, vol. 49, no. 1, pp. 139–145, 2017. View at Publisher · View at Google Scholar · View at Scopus
  38. R. Joehanes, X. Zhang, T. Huan et al., “Integrated genome-wide analysis of expression quantitative trait loci aids interpretation of genomic association studies,” Genome Biology, vol. 18, no. 1, p. 16, 2017. View at Publisher · View at Google Scholar · View at Scopus
  39. A. A. Shabalin, “Matrix eQTL: Ultra fast eQTL analysis via large matrix operations,” Bioinformatics, vol. 28, no. 10, pp. 1353–1358, 2012. View at Publisher · View at Google Scholar · View at Scopus
  40. N. Itoh, Y. Itoh, A. Tassoni et al., “Cell-specific and region-specific transcriptomics in the multiple sclerosis model: Focus on astrocytes,” Proceedings of the National Acadamy of Sciences of the United States of America, vol. 115, no. 2, pp. E302–E309, 2018. View at Publisher · View at Google Scholar
  41. C. F. Spurlock 3rd, J. T. Tossberg, Y. Guo, S. Sriram, P. S. Crooke 3rd, and T. M. Aune, “Defective structural RNA processing in relapsing-remitting multiple sclerosis,” Genome Biology, vol. 16, no. 1, p. 58, 2015. View at Publisher · View at Google Scholar · View at Scopus
  42. N. L. Bray, H. Pimentel, P. Melsted, and L. Pachter, “Near-optimal probabilistic RNA-seq quantification,” Nature Biotechnology, vol. 34, no. 5, pp. 525–527, 2016. View at Publisher · View at Google Scholar · View at Scopus
  43. H. Li and R. Durbin, “Fast and accurate short read alignment with Burrows-Wheeler transform,” Bioinformatics, vol. 25, no. 14, pp. 1754–1760, 2009. View at Publisher · View at Google Scholar · View at Scopus
  44. H. Li, B. Handsaker, A. Wysoker et al., “The sequence alignment/map format and SAMtools,” Bioinformatics, vol. 25, no. 16, pp. 2078-2079, 2009. View at Publisher · View at Google Scholar · View at Scopus
  45. C. Ober, D. A. Loisel, and Y. Gilad, “Sex-specific genetic architecture of human disease,” Nature Reviews Genetics, vol. 9, no. 12, pp. 911–922, 2008. View at Publisher · View at Google Scholar · View at Scopus
  46. K. R. Kukurba, P. Parsana, B. Balliu et al., “Impact of the X chromosome and sex on regulatory variation,” Genome Research, vol. 26, no. 6, pp. 768–777, 2016. View at Publisher · View at Google Scholar · View at Scopus
  47. B. L. Aken, P. Achuthan, W. Akanni et al., “Ensembl 2017,” Nucleic Acids Research, vol. 45, no. D1, pp. D635–D642, 2017. View at Publisher · View at Google Scholar